Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-09-23
1989-09-19
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546194, 546210, 546197, 514326, 514321, A61K 31445, C07D21168, C07D40100
Patent
active
048681946
ABSTRACT:
The present invention is directed to a new class of piperidinyl imidazole antiarrhythmic agents and to methods for treating arrhythmias.
REFERENCES:
patent: 4791121 (1988-12-01), Kudzma et al.
Selective Class III Antiarrhythmic Drug Candidates; Rationale and Serendipity in Design and Development of Different Structural Classes, William Lumma et al., presented at 21st National Medicinal Chemistry Symposium on Jun. 19-23, 1988 in Minneapolis, Minnesota.
Carr Albert A.
Dage Richard C.
Hay David A.
Koerner John E.
Li Tung
Dixon J. Michael
Lee Mary C.
Merrell Dow Pharmaceuticals Inc.
Whittenbaugh Robert C.
LandOfFree
Imidazole antiarrhythmics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole antiarrhythmics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole antiarrhythmics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-368936